Back to results
US 2021/0060022 A1Published application
Treatment of cancers using pi3 kinase isoform modulators
AssigneeInfinity Pharmaceuticals, Inc.
InventorsHoward M. Stern, Jeffrey L. Kutok
Life of this patent
Estimating the term…
Abstract
Provided herein are methods, kits, and pharmaceutical compositions that include a P13 kinase inhibitor for treating cancers or hematologic disorders.
Claims21
-94. (canceled)
A method of treating a hematologic malignancy in a human subject in need thereof, comprising orally administering to the subject twice daily about 15 mg to about 75 mg of a compound having the following structure or a pharmaceutically acceptable salt, solvate, hydrate, co-crystal, clathrate, or polymorph thereof:
Dependencies are inferred from the claim text.